Recent Student Publications

Listed here is a selection of recent publications by current students.

Genomic and Transcriptomic Profiling of High-risk Bladder Cancer Reveals Diverse Molecular and Microenvironment Ecosystems.
Meghani K, Yu Y, Frydenlund N, Li EZ, Choy B, Abdulkadir SA, Meeks JJ.
Eur Urol. 2026 Apr;89(4):346-352. doi: 10.1016/j.eururo.2025.09.4138. Epub 2025 Oct 7.
FOXA1 loss drives basal/squamous de-differentiation of prostate cancer and induces an immunosuppressive tumor microenvironment.
Brea L, et al. Among authors: keo v.
Nat Commun. 2026 Mar 28. doi: 10.1038/s41467-026-71121-8. Online ahead of print.
Microglial fructose metabolism is essential for glioblastoma growth.
Billingham LK, et al. Among authors: murphy ar.
Proc Natl Acad Sci U S A. 2026 Mar 24;123(12):e2521256123. doi: 10.1073/pnas.2521256123. Epub 2026 Mar 17.
Adipocyte NADH dehydrogenase reverses circadian and diet-induced metabolic syndrome.
Hepler C, et al. Among authors: weidemann bj, waldeck nj.
Nat Metab. 2026 Mar;8(3):559-571. doi: 10.1038/s42255-026-01464-5. Epub 2026 Feb 18.
Human CRAMP1 specifically promotes the expression of histone H1 genes.
Bodner J, et al. Among authors: khurana s.
EMBO Rep. 2026 Mar;27(5):1122-1145. doi: 10.1038/s44319-026-00704-9. Epub 2026 Feb 9.
A role for the cholinergic neuron circadian clock in RNA metabolism and mediating neurodegeneration.
Tam SB, Waldeck NJ, Wright M, Mojsilovic-Petrovic J, Baker EM, Kiskinis E, Bass J, Kalb RG.
Life Sci Alliance. 2025 Dec 15;9(3):e202503508. doi: 10.26508/lsa.202503508. Print 2026 Mar.
Suppression of cardiac allograft vasculopathy by a macrophage efferocytosis receptor.
Shah S, Ananthakrishnan A, DeBerge M, Glinton K, Jones RTL, Filipp M, Shen I, Lockhart J, Lantz CW, Thorp EB.
Am J Transplant. 2026 Mar;26(3):455-466. doi: 10.1016/j.ajt.2025.08.026. Epub 2025 Aug 26.
Imputation of urban environmental sensor data using gated attention bidirectional long short-term memory (GA-BiLSTM): methods, performance, and implications.
Lee J, Berkelhammer M, O'Brien J, McNicol G, Vincent AES, Grover M, Packman AI, Kaludi B, Cho A, Gonzalez-Meler M.
Environ Monit Assess. 2026 Feb 27;198(3):262. doi: 10.1007/s10661-026-15112-8.
Heterobifunctional proteomimetic polymers for targeted degradation of MYC and KRAS.
Wang MM, Truica MI, Gattis BS, Oktawiec J, Sagar V, Basu AA, Bertin PA, Zhang X, Abdulkadir SA, Gianneschi NC.
Nat Commun. 2026 Feb 24;17(1):1706. doi: 10.1038/s41467-026-68913-3.
EZH2 PROTACs outperform catalytic inhibitors in prostate cancer by targeting a methylation-independent function of PRC2.
Xie W, et al. Among authors: brea l.
Oncogene. 2026 Feb;45(5):636-649. doi: 10.1038/s41388-025-03662-z. Epub 2026 Jan 7.